Zacks Small Cap Comments on WINT FY2024 Earnings
Windtree Therapeutics, Inc. (NASDAQ:WINT – Free Report) – Equities research analysts at Zacks Small Cap issued their FY2024 EPS estimates for Windtree Therapeutics in a research note issued on Tuesday, March 4th. Zacks Small Cap analyst M. Marin anticipates that the company will earn ($3.80) per share for the year. The consensus estimate for Windtree […]
